ICU Medical, Inc. (NASDAQ:ICUI) has received an average broker rating score of 2.20 (Buy) from the five analysts that cover the stock, Zacks Investment Research reports. Three investment analysts have rated the stock with a hold rating and two have assigned a strong buy rating to the company.

Brokerages have set a 1 year consensus target price of $175.67 for the company and are anticipating that the company will post $0.73 EPS for the current quarter, according to Zacks. Zacks has also given ICU Medical an industry rank of 188 out of 265 based on the ratings given to its competitors.

Several brokerages have recently weighed in on ICUI. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a report on Friday, July 14th. Sidoti lowered ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. BidaskClub lowered ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Finally, Gabelli restated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th.

ICU Medical (NASDAQ ICUI) opened at 182.85 on Tuesday. The stock has a market cap of $3.62 billion, a PE ratio of 73.23 and a beta of 0.36. The stock has a 50 day moving average price of $172.80 and a 200-day moving average price of $164.16. ICU Medical has a 12 month low of $121.78 and a 12 month high of $183.55.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The business had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. During the same quarter last year, the firm posted $1.15 EPS. The company’s revenue was up 242.8% compared to the same quarter last year. On average, analysts expect that ICU Medical will post $4.11 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Zacks: ICU Medical, Inc. (ICUI) Receives Average Recommendation of “Buy” from Analysts” was originally published by Watch List News and is owned by of Watch List News. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.watchlistnews.com/zacks-icu-medical-inc-icui-receives-average-recommendation-of-buy-from-analysts/1573025.html.

In other news, VP Virginia Ruth Sanzone sold 1,784 shares of the company’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $174.47, for a total value of $311,254.48. Following the completion of the sale, the vice president now owns 102 shares in the company, valued at $17,795.94. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Robert S. Swinney sold 463 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $181.25, for a total value of $83,918.75. Following the completion of the sale, the director now owns 14,330 shares of the company’s stock, valued at approximately $2,597,312.50. The disclosure for this sale can be found here. In the last 90 days, insiders sold 213,012 shares of company stock valued at $36,438,659. Insiders own 15.90% of the company’s stock.

Several institutional investors have recently made changes to their positions in the company. Janney Montgomery Scott LLC lifted its holdings in shares of ICU Medical by 0.4% in the first quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock valued at $245,000 after buying an additional 7 shares during the period. Alps Advisors Inc. lifted its holdings in shares of ICU Medical by 0.3% during the second quarter. Alps Advisors Inc. now owns 3,130 shares of the medical instruments supplier’s stock valued at $540,000 after purchasing an additional 8 shares during the last quarter. Texas Permanent School Fund lifted its holdings in shares of ICU Medical by 0.3% during the first quarter. Texas Permanent School Fund now owns 10,747 shares of the medical instruments supplier’s stock valued at $1,641,000 after purchasing an additional 28 shares during the last quarter. Municipal Employees Retirement System of Michigan lifted its holdings in shares of ICU Medical by 1.2% during the first quarter. Municipal Employees Retirement System of Michigan now owns 3,360 shares of the medical instruments supplier’s stock valued at $513,000 after purchasing an additional 40 shares during the last quarter. Finally, Meadow Creek Investment Management LLC lifted its holdings in shares of ICU Medical by 1.4% during the first quarter. Meadow Creek Investment Management LLC now owns 3,146 shares of the medical instruments supplier’s stock valued at $480,000 after purchasing an additional 44 shares during the last quarter. Institutional investors and hedge funds own 78.13% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Get a free copy of the Zacks research report on ICU Medical (ICUI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.